The Vivalytic SARS-CoV-2 DT rapid PCR test
The Vivalytic rapid PCR test delivers results in just 30 to 49 minutes*. With these reliable and quick diagnoses, infections can be detected much faster.
Fast results thanks to the Vivalytic SARS-CoV-2 PCR test
With over 250 million cases and 5 million deaths reported worldwide by the end of 2021 alone, COVID-19 poses major challenges for the healthcare system and our society in general. In order to efficiently prevent the rapid spread of the SARS-CoV-2 virus, infection chains must be quickly identified and stopped – to this end, the Vivalytic SARS-CoV-2 test provides a fast and reliable solution directly at the point of care. The dual target strategy offers a robust test in an environment with low prevalance and low test indications.
Vivalytic analyses the nasal/throat swab or lolly-saliva swab sample fully automatically in just 30 to 49 minutes* and directly delivers comprehensive results. The Bosch Vivalytic SARS-CoV-2 DT is an automated qualitative in vitro diagnostic test based on real time of the E-gene of SARS-coronavirus-2 from human nasopharyngeal, oropharyngeal or lolly-saliva swabs to aid in the diagnosis for SARS-CoV-2 infection of symptomatic or asymptomatic individuals.
Easy handling and fewer steps for sample preparation make the Vivalytic system particularly suitable for on-site testing. As a result, time-consuming logistics chains in which samples have to be transported to the laboratory become obsolete.
Vivalytic's automated process helps make the correct diagnosis much faster, gaining valuable time for medical staff in combatting the pandemic.
Thanks to its intuitive operation, tests can be easily and reliably carried out and evaluated by healthcare professionals – after only a minimum of training. This way, all resources can be put to optimal use in order to contain the pandemic and ensure everyone's safety.
Detectable viral pathogens:
- SARS coronavirus 2 (SARS-CoV-2) dual target (E-gene, N-gene)
Your advantages
Vivalytic stands for high efficiency and safety with minimum effort. The unique Vivalytic platform provides ideal assistance for everyday work in clinics, practices, laboratories and other points of need – especially when it comes to combatting the pandemic.
Comprehensive results
The rapid PCR test for SARS-CoV-2 from Vivalytic only takes 39 minutes to analyze a sample.
High accuracy
The Vivalytic SARS-CoV-2 rapid PCR test delivers reliable results with high accuracy.
Easy handling
Like all Vivalytic tests, the SARS-CoV-2 PCR test is fully automated. This allows for fewer work steps, saving valuable time.
*Test Termination: If one of the target genes is clearly detected, the test can be terminated prematurely with the valid positive result.
.
See how easy the SARS-CoV-2 PCR test with Vivalytic is
What exactly happens in the Vivalytic Analyser?
The Vivalytic Analyser automates complex, molecular diagnostic processes that previously had to be carried out manually. This promotes high safety and quick availability of the test results.
| 1. Step | 2. Step | 3. Step | 4. Step | 5. Step |
|---|---|---|---|---|
|
1. Step
Preparing the sample
|
2. Step
Cell lysis
|
3. Step
Extraction of the nucleic acid
|
4. Step
DNA amplification
|
5. Step
Bio-analytical detection
|
1. Step
|
2. Step
|
3. Step
|
4. Step
|
5. Step
|
|
1. Step
Samples are processed reliably.
|
2. Step
The external membrane of the cells is broken down through ultrasound.
|
3. Step
The nucleic acid (DNA/RNA) is purified for the PCR amplification.
|
4. Step
Specific DNA sequences are multiplied using PCR.
|
5. Step
The amplified DNA is identified by detecting a fluorescence or chemiluminescence signal.
|
Get the new PCR test with Vivasuite
You can conveniently carry out updates remotely via the digital platform for Vivalytic products. This means that you will always have the latest tests.
Frequently asked questions
Do you have any questions? We have the answers.
The Vivalytic Analyser is so user-friendly that even healthcare professionals who have not been specially trained can reliably perform the test evaluation. The devices and the rapid tests are not intended to be used for private or non-medical purposes.
A nasopharyngeal swab sample is taken from a patient's nose or throat using a swab with eNAT transport medium.
In various laboratory tests involving SARS-CoV-2, the test provided results with an accuracy of over 95 percent.
For Vivalytic, no other peripheral devices like laptop, keyboard, barcode scanner, or filling stations are required.
The test to detect SARS-CoV-2 provides results after just 39 minutes.